Oncotelic Therapeutics, Inc. (OTLC) › Capital ExpendituresOncotelic Therapeutics, Inc. (OTLC) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $109.0K2014: $17.0K2015: $13.0K$13.0K2009Capital Expenditures (USD)2015Fiscal YearCapital ExpendituresChange YoY2015$13.0K-23.5%2014$17.0K—2009$109.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share